In order to elucidate the complex relationship between BDNF, pain, and depression in the nociplastic FM and chronic nociceptive pain, it seems reasonable to explore the effect of approved medications for FM and depression on the BDNF level in the painful conditions and also to assess the relationships of BDNF changes with the clinical indices’ improvement. The gene discussed is BDNF; the disease is depressive disorder.